期刊文献+

血浆高同型半胱氨酸与初发卒中患者心脑血管疾病死亡风险的关系

Elevated Plasma Homocysteine Levels Contribute to the Risk of Cardio-cerebrovascular Mortality in a Large Prospective Stroke Population
下载PDF
导出
摘要 目的探讨初发卒中患者的血浆同型半胱氨酸水平与心脑血管死亡风险的关系。方法对1823例卒中病例队列(包括808例动脉粥样硬化性血栓性脑梗死、513例腔隙性脑梗死和502例脑出血)进行长期的前瞻性随访,Cox生存回归模型分析血浆同型半胱氨酸水平与总死亡和心脑血管死亡风险的相关性。结果随访0.1~6.0年(中位数4.5年),323例卒中病例死亡,其中183例死于心脑血管疾病。与血浆同型半胱氨酸<16μmol/L组比较,同型半胱氨酸≥16μmol/L组患者死亡风险显著增加,校正年龄、性别和传统心血管危险因素后,相对风险为1.47(95%可信区间1.15~1.88)。进一步分析表明血浆高同型半胱氨酸与卒中患者总死亡的相关性主要是由于心脑血管疾病死亡,相对风险为1.33(95%可信区间1.06~1.65)。亚型分析显示,血浆高同型半胱氨酸与脑梗死组和脑出血组的心脑血管疾病死亡风险均显著相关。结论血浆同型半胱氨酸水平升高是卒中患者心脑血管疾病死亡风险增加的独立预测因素。 Objective To assess whether elevated plasma homocysteine levels contribute to the risk of cardio-cerehrovascular mortality in a large prospective cohort of patients with first onset stroke in Chinese population. Methods A total of 1,823 patients with first onset stroke(35-74 years) were recruited during 2000-2001, including 808 paitents with cerebral thrombosis, 513 paitents with lacunar infarction, and 502 patients with intracerebral hemorrhage. These stroke patients were followed up annually until May 31, 2006 by a standard questionnaire and telephone contact by physician investigators. Cox proportional-hazards models were used to examine the association between homocysteine(Hcy) and all-cause or cardio-cerebrovascular mortality. Results During a median of 4.5-year follow-up, a total of 323 deaths from all causes were documented, including 183 deaths from recurrent stroke and coronary heart disease. After adjustment for age, sex, and conventional vascular risk factors, high Hcy level(〉16 μmol/L) was significantly associated with increased risk of all-cause mortality[relative risk(RR) 1.47, 95% confidence interval(CI) 1.15-1.88] as compared with lower Hcy level(〈16μmol/L). The association with all-cause mortality was mainly due to a positive association between homocysteine and the risk of cardiovascular deaths, and RR was 1.33(95%CI 1.06-1.65). Stroke subtype analysis showed that high Hcy level increased the risk of cardiovascular deaths not only in the patients with atherothrombotic stroke but also in those with hemorrhagic stroke. Conclusion Our findings suggest that elevated plasma homocysteine levels are independently associated with increased risk of cardio-cerebrovascular mortality in the patients with first onset stroke.
出处 《中国卒中杂志》 2009年第9期747-751,共5页 Chinese Journal of Stroke
基金 国家自然科学基金资助项目(30670862) 国家973重点基础研究发展规划基金资助项目(G2006CB503805)
关键词 半胱氨酸 卒中 血管疾病 危险因素 Cysteine Stroke Vascular diseases Mortality Risk factors
  • 相关文献

参考文献12

  • 1张继红,李雪松,陈晶,宫旭海,刘江华,宋来军,杨凤民.高同型半胱氨酸血症与卒中的关系[J].中国卒中杂志,2008,3(10):716-720. 被引量:4
  • 2赵冬,吴兆苏,王薇,刘静,吴桂贤,曾哲淳,王文化,刘军,秦兰萍,刘飒.中国11省市队列人群基线血压和7年累积心血管病发病危险的前瞻性研究[J].中华心血管病杂志,2001,29(10):612-617. 被引量:226
  • 3Lonn E,Yusuf S,Arnold MJ,et al.Homocysteine loweringwith folic acid and B vitamins in vascular disease[].The New England Journal of Medicine.2006
  • 4Toole JF,Malinow MR,Chambless LE,et al.Lowering homocys-teine in patients with ischemic stroke to prevent recurrent stroke,myocardial infarction,and death:The Vitamin Intervention for Stroke Prevention(VISP)randomized controlled trial[].The Journal of The American Medical Association.2004
  • 5Yang,Q.,Botto,L.D.,Erickson,D.Improvement in stroke mortality in Canada and the United States, 1990–2002[].Circulation.2006
  • 6The Homocysteine Studies Collaboration.Homocysteine and risk of ischemic heart disease and stroke: a Meta-analysis[].The Journal of The American Medical Association.2002
  • 7Wang,X.,Qin,X.,Demirtas,H.Efficacy of folic acid supplementation in stroke prevention: a meta-analysis[].The Lancet.2007
  • 8Del Ser T,Barba R,Herranz AS,et al.Hyperhomocysteinemia is a risk factor of secondary vascular events in stroke patients[].Cerebrovascular Diseases.2001
  • 9Jiang He,Dongfeng Gu,Xigui Wu,et al.Major causes of death among men and women in China[].The New England Journal of Medicine.2005
  • 10Boysen G,Brander T,Christensen H,et al.Homocysteine and risk of recurrent stroke[].Stroke.2003

二级参考文献25

  • 1王宏利,樊东升,沈扬,孙阿萍,张捷,杨玉杰.颈动脉硬化症与高同型半胱氨酸血症关系的研究[J].中华内科杂志,2005,44(4):258-261. 被引量:68
  • 2Weisberg S.应用线性回归[M].北京:中国统计出版社,1998..
  • 3[2]Perry IJ,Refsum H,Morris RW,et al.Prospective study of serum totalhomocystine concentration and risk of stroke in middle-aged British men[J].Lancet,1995,346:1395-1398.
  • 4[3]Howard JV,Sides GE,Newman CG.Changes in plasma homoeysteine in the acute phase after stroke[J].Stroke,2002,33:473-478.
  • 5[4]Boysen G,Brande T,Christensen H,et al.Homocysteine and risk of recurrent stroke[J].Stroke,2003,34:1258-1261.
  • 6[5]Malinow MR,Bostom AG,Krauss RM.Homocystine,diet and cardiovasculat diseases:a statement for healthcare professionals from the Nutrition Committee,American Heart Association[J].Circulation,1999,99:178-182.
  • 7[6]Malinow MR.Plasma homocysteine:A risk factor for arterial occlu-sive disease[J].J Mutr,1996,126(4 suppl):1238s-1243s.
  • 8[7]Coull BM,Malinow MR,Beamer N,et al.Elevated plasma homo-cysteine concentration as a possible independent risk factor forstroke[J].Stroke,1990,21:572-576.
  • 9[8]Glueck CJ,Shaw P,Lang JE,et al.Evidence that homocysteine isan independent risk factor for artherosclerosis in hyperlipidemic pa-tients[J].Am J Cardiol,1995,75:132-136.
  • 10[9]Selhub J,D'Aangelo A.Relationship between homocysteine andthrombotic disease[J].Am J Med Sci,1998,316:129-141.

共引文献228

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部